This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Glaxo Group Limited. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Bams Abila: Innovator in Stroke Treatment
Introduction
Bams Abila is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of medical treatment, particularly in the area of stroke therapy. His innovative approach focuses on the use of anti-MAG antibodies to improve patient outcomes.
Latest Patents
Bams Abila holds a patent for the "Treatment of stroke comprising anti-MAG antibodies." This invention relates to a dosing regimen for the treatment of stroke, specifically addressing the administration of two doses of anti-MAG antibodies for ischemic and/or hemorrhagic stroke. This patent highlights his commitment to advancing medical science and improving therapeutic options for stroke patients. He has 1 patent to his name.
Career Highlights
Bams Abila is associated with Glaxo Group Limited, a prominent company in the pharmaceutical industry. His work at Glaxo Group Limited has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to medical research.
Collaborations
Throughout his career, Bams has worked alongside notable colleagues such as Lori Ann Enney and Seth Paul Finklestein. These collaborations have played a crucial role in the development of his innovative treatments.
Conclusion
Bams Abila is a dedicated inventor whose work in stroke treatment exemplifies the impact of innovation in healthcare. His patent for the treatment of stroke using anti-MAG antibodies represents a significant advancement in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile